CompletedNCT00521794
Characteristics of Andersen-Tawil Syndrome
Studying Andersen-Tawil syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Rochester
- Principal Investigator
- Emma Ciafaloni, MDUniversity of Rochester
- Enrollment
- 28 enrolled
- Eligibility
- 10 years · All sexes
- Timeline
- 2007 – 2012
Study locations (7)
- University of California, San Francisco, San Francisco, California, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- University of Rochester School of Medicine and Dentistry, Rochester, New York, United States
- University of Texas Southwestern Medical Center, Dallas, Texas, United States
- London Health Sciences Centre, London, Ontario, Canada
- University of Milan, Milan, Italy
- Institute of Neurology and National Hospital for Neurology, London, United Kingdom
Collaborators
Office of Rare Diseases (ORD) · Rare Diseases Clinical Research Network · National Center for Research Resources (NCRR)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00521794 on ClinicalTrials.gov